HIGHLIGHTS
- who: Simona Cintoli and colleagues from the Neurology Unit, Santa Chiara University Hospital, Pisa, Italy have published the research: Could Temperamental Features Modulate Participation in Clinical Trials?, in the Journal: (JOURNAL)
- what: The prodromal stages of Alzheimer`s disease (AD) are the primary focus of research aimed at slowing disease progression. This study explores the influence of affective temperament on the motivation of people with mild cognitive impairment (MCI) and subjective cognitive decline (SCD) to participate in clinical trials. The authors focused on examining the temperamental traits of individuals experiencing cognitive difficulties who demand medical . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.